Internal Medicine Doctors in Boulder City, NV Accepting Medicare
2 Internal Medicine doctors found. Showing 1 - 2
 Michael Falvo, DO Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1297 Nevada Hwy, Suite A, Boulder City, NV 89005 Phone: 702-294-1919 Fax: 702-294-0072 |
 Leila R. Olivera, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1297 Boulder City Pkwy Ste A, Boulder City, NV 89005 Phone: 702-294-1919 Fax: 702-294-0072 |
News Archive
New guideline for HER2 testing in breast cancer benefits patients and clinicians
Published today, a Focused Update to the American Society of Clinical Oncology/College of American Pathologists guideline for human epidermal growth factor receptor 2 (HER2) testing in breast cancer brings new levels of clarity that will benefit patients and clinical teams alike.
Genkyotex announces initiation of GKT137831 Phase II study in patients with diabetic nephropathy
Genkyotex, the leading developer of selective NOX enzyme inhibitors, announced today the initiation of a multinational Phase II clinical study of GKT137831 in patients with diabetic nephropathy.
Single dose of Ritalin may raise awareness of mistakes: Study
The study, by Dr Rob Hester from the Department of Psychological Sciences and colleagues at the Queensland Brain Institute, investigated how the brain monitors ongoing behavior for performance errors – specifically failures of impulse control. This study found that a single dose of methylphenidate (Ritalin) results in significantly greater activity in the brain's error monitoring network and improved volunteers' awareness of their mistakes.
Including evangelical Christians in U.S. foreign aid discussion
"Washington is in an era of budget-cutting, so we frequently hear calls to shrink or eliminate U.S. foreign-assistance programs," which is why "several religious groups ... are highlighting how these programs reduce global poverty and hunger, saving millions of lives," Richard Stearns, president of World Vision USA, writes in a Wall Street Journal opinion piece.
ISA Pharmaceuticals announces initiation of ISA101 Phase I/II trial in HIV-positive men with AIN
ISA Pharmaceuticals B.V., a clinical-stage biopharmaceutical company focusing on rationally designed, fully synthetic therapeutic vaccines against cancer and persistent viral infections, today announced the initiation of a Phase I/II clinical study of its lead candidate ISA101 in HIV-positive men suffering from anal intraepithelial neoplasia.
› Verified 1 days ago